SCHEMBL14918447

SCHEMBL14918447

COC(=O)c1ccc(OC2CCN(C3CCN(C(=O)O)C(C(C)(C)C)C3)C2=O)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.34
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
KCNH2 Q12809 1/20 0.33
AXL P30530 1/20 0.32
TYRO3 Q06418 1/20 0.32
MERTK Q12866 1/20 0.32
KMT2A Q03164 1/20 0.32
NOTUM Q6P988 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
MCHR1 Q99705 5/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2597221 0.79 GPR119 (0.47) ALDH1A1KMT2A
SCHEMBL14918071 0.79 GPR119 (0.47) ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL2597136 0.78 ALOX15 (0.40) ATMALDH1A1SMN1; SMN2NPSR1ALOX15
Hydrochloric Acid SCHEMBL14918155 0.78 ALOX15 (0.40) ATMALDH1A1SMN1; SMN2NPSR1ALOX15
SCHEMBL14918034 0.73 KMT2A (0.37) ATMALDH1A1OPRM1OPRK1KCNH2
SCHEMBL2597097 0.72 OPRK1 (0.41) SMN1; SMN2OPRK1AXLTYRO3MERTK
SCHEMBL2597096 0.72 OPRK1 (0.41) SMN1; SMN2OPRK1AXLTYRO3MERTK
SCHEMBL2596996 0.72 GPR119 (0.48) SMN1; SMN2KMT2A
SCHEMBL2596997 0.72 GPR119 (0.48) SMN1; SMN2KMT2A
SCHEMBL2597125 0.71 MAPT (0.55) ALDH1A1SMN1; SMN2NPSR1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256756-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA, INC. 2014-09-11 US disclosed
WO-2013066869-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA INC. (US) 2013-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256756-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS GPR119, GPR139, GLP1R ATM 3656/4885ALDH1A1 2778/4885SMN1; SMN2 3196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.